Beau R. Webber Department of Pediatrics University of Minnesota Biography Publications Institution JoVE Articles Beau R. Webber has not added a biography. If you are Beau R. Webber and would like to personalize this page please email our Author Liaison for assistance. Publications Efficient Targeted Integration Directed by Short Homology in Zebrafish and Mammalian Cells ELife. May, 2020 | Pubmed ID: 32412410 A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy Molecular Therapy : the Journal of the American Society of Gene Therapy. 01, 2020 | Pubmed ID: 31704085 Base Editor Correction of COL7A1 in Recessive Dystrophic Epidermolysis Bullosa Patient-Derived Fibroblasts and IPSCs The Journal of Investigative Dermatology. 02, 2020 | Pubmed ID: 31437443 Author Correction: Highly Efficient Multiplex Human T Cell Engineering Without Double-strand Breaks Using Cas9 Base Editors Nature Communications. Dec, 2019 | Pubmed ID: 31811147 Highly Efficient Multiplex Human T Cell Engineering Without Double-strand Breaks Using Cas9 Base Editors Nature Communications. 11, 2019 | Pubmed ID: 31745080 EditR: A Method to Quantify Base Editing from Sanger Sequencing The CRISPR Journal. 06, 2018 | Pubmed ID: 31021262 Highly Multiplexed Genome Engineering Using CRISPR/Cas9 GRNA Arrays PloS One. 2018 | Pubmed ID: 30222773 Engineering of Primary Human B Cells with CRISPR/Cas9 Targeted Nuclease Scientific Reports. 08, 2018 | Pubmed ID: 30108345 CRISPR/Cas9-Based Cellular Engineering for Targeted Gene Overexpression International Journal of Molecular Sciences. Mar, 2018 | Pubmed ID: 29565806 Rapid DNA Replication Origin Licensing Protects Stem Cell Pluripotency ELife. 11, 2017 | Pubmed ID: 29148972 Rapid Generation of Col7a1 Mouse Model of Recessive Dystrophic Epidermolysis Bullosa and Partial Rescue Via Immunosuppressive Dermal Mesenchymal Stem Cells Laboratory Investigation; a Journal of Technical Methods and Pathology. 10, 2017 | Pubmed ID: 28892093 Dermatopontin in Bone Marrow Extracellular Matrix Regulates Adherence but Is Dispensable for Murine Hematopoietic Cell Maintenance Stem Cell Reports. 09, 2017 | Pubmed ID: 28844660 CRISPR/Cas9-Mediated Correction of the FANCD1 Gene in Primary Patient Cells International Journal of Molecular Sciences. Jun, 2017 | Pubmed ID: 28613254 Aryl Hydrocarbon Receptor Inhibition Promotes Hematolymphoid Development from Human Pluripotent Stem Cells Blood. 06, 2017 | Pubmed ID: 28533309 Angiotensin Receptor Blockade Mediated Amelioration of Mucopolysaccharidosis Type I Cardiac and Craniofacial Pathology Journal of Inherited Metabolic Disease. 03, 2017 | Pubmed ID: 27743312 CRISPR/Cas9-based Genetic Correction for Recessive Dystrophic Epidermolysis Bullosa NPJ Regenerative Medicine. 2016 | Pubmed ID: 28250968 CRISPR/Cas9 Targeted Gene Editing and Cellular Engineering in Fanconi Anemia Stem Cells and Development. 10, 2016 | Pubmed ID: 27538887 Evaluation of TCR Gene Editing Achieved by TALENs, CRISPR/Cas9, and MegaTAL Nucleases Molecular Therapy : the Journal of the American Society of Gene Therapy. Mar, 2016 | Pubmed ID: 26502778 In Vitro T-Cell Generation From Adult, Embryonic, and Induced Pluripotent Stem Cells: Many Roads to One Destination Stem Cells (Dayton, Ohio). Nov, 2015 | Pubmed ID: 26227158 From Marrow to Matrix: Novel Gene and Cell Therapies for Epidermolysis Bullosa Molecular Therapy : the Journal of the American Society of Gene Therapy. Jun, 2015 | Pubmed ID: 25803200 Fanconi Anemia Gene Editing by the CRISPR/Cas9 System Human Gene Therapy. Feb, 2015 | Pubmed ID: 25545896 Trp53 Haploinsufficiency Modifies EGFR-driven Peripheral Nerve Sheath Tumorigenesis The American Journal of Pathology. Jul, 2014 | Pubmed ID: 24832557 DNA Methylation of Runx1 Regulatory Regions Correlates with Transition from Primitive to Definitive Hematopoietic Potential in Vitro and in Vivo Blood. Oct, 2013 | Pubmed ID: 24030384 TALEN-based Gene Correction for Epidermolysis Bullosa Molecular Therapy : the Journal of the American Society of Gene Therapy. Jun, 2013 | Pubmed ID: 23546300 CRISPR/Cas9를 사용하여 1차 인간 B 세포의 게놈 공학 Kanut Laoharawee1,2,3, Matthew J. Johnson1,2,3, Walker S. Lahr1,2,3, Joseph J. Peterson1,2,3, Beau R. Webber1,2,3, Branden S. Moriarity1,2,3 1Department of Pediatrics, University of Minnesota, 2Center for Genomic Engineering, University of Minnesota, 3Masonic Cancer Center, University of Minnesota JoVE 61855 Biology
CRISPR/Cas9를 사용하여 1차 인간 B 세포의 게놈 공학 Kanut Laoharawee1,2,3, Matthew J. Johnson1,2,3, Walker S. Lahr1,2,3, Joseph J. Peterson1,2,3, Beau R. Webber1,2,3, Branden S. Moriarity1,2,3 1Department of Pediatrics, University of Minnesota, 2Center for Genomic Engineering, University of Minnesota, 3Masonic Cancer Center, University of Minnesota JoVE 61855 Biology
